Clinical trial
The Impact of Oestrogen Administration on Covid-19 Disease
NCT04853069 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Oestrogen Administration on Covid-19 Disease
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 17, 2021
- Completion date
- March 31, 2022
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.